evidence table
Alpha Lipoic Acid Cognition Randomized Trial Evidence Table
Structured evidence table for Alpha Lipoic Acid Cognition Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Alpha Lipoic Acid Cognition Randomized Trial | Objectives This review aims to critically synthesize mechanistic, preclinical, and clinical evidence on α-lipoic acid and biotin as candidate neuroprotective agents in neurodegenerative diseases, with emphasis on shared signaling pathways, therapeutic potential, generally favorable safety profiles, and translational limitations. | 4 | Aguilera-Méndez A (2026) | Alpha-Lipoic Acid and Biotin in Neurodegenerative Diseases: Convergent Mechanistic Insights from Preclinical Models to Clinical Perspectives. |
| Alpha Lipoic Acid Cognition Randomized Trial | The evidence was qualitatively analyzed with attention to biological plausibility, consistency across models, and clinical relevance. | 4 | Aguilera-Méndez A (2026) | Alpha-Lipoic Acid and Biotin in Neurodegenerative Diseases: Convergent Mechanistic Insights from Preclinical Models to Clinical Perspectives. |
| Alpha Lipoic Acid Cognition Randomized Trial | In contrast, clinical evidence remains heterogeneous, with more extensive evaluation of biotin in progressive multiple sclerosis and more limited or exploratory findings for ALA across neurodegenerative disorders. | 4 | Aguilera-Méndez A (2026) | Alpha-Lipoic Acid and Biotin in Neurodegenerative Diseases: Convergent Mechanistic Insights from Preclinical Models to Clinical Perspectives. |
| Alpha Lipoic Acid Cognition Randomized Trial | Background Neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and amyotrophic lateral sclerosis, represent a major global health burden and share convergent pathogenic mechanisms, such as mitochondrial dysfunction, oxidative stress, neuroinflammation, calcium imbalance, and neuronal loss. | 4 | Aguilera-Méndez A (2026) | Alpha-Lipoic Acid and Biotin in Neurodegenerative Diseases: Convergent Mechanistic Insights from Preclinical Models to Clinical Perspectives. |
Source documents